Saturday, July 4, 2020

AstraZeneca#39;s Dapagliflozin gets DCGI nod for treatment of heart failure patients

AstraZeneca#39;s Dapagliflozin gets DCGI nod for treatment of heart failure patients The company has received import and market permission from DCGI in Form CT-20 (Marketing Authorisation- Additional Indication).

from Moneycontrol Business News https://ift.tt/2ZAr8KR

No comments:

Post a Comment

US equities end lower as valuation concerns creep in

U.S. stocks closed lower on Wednesday as investors took profits amid concerns about high valuations flagged by Fed Chair Powell. The market ...